BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells. Prostate 2002;53:211-7. [DOI: 10.1002/pros.10146] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Salman EK, Badr ES, Ghoniem KE, Aboulila AA, Emeran AA. Role of silymarin induced rice immunity against blast pathogen Magnaporthe oryzae through regulation of resistance genes expression. Physiological and Molecular Plant Pathology 2021;115:101678. [DOI: 10.1016/j.pmpp.2021.101678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Habán M, Zvercová D, Adamjaková M. Evaluation of variability of silymarin complex in Silybi mariani fructus harvested during two production years. European Pharmaceutical Journal 2021;68:40-5. [DOI: 10.2478/afpuc-2020-0023] [Reference Citation Analysis]
4 Delmas D, Xiao J, Vejux A, Aires V. Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity. Molecules 2020;25:E2009. [PMID: 32344919 DOI: 10.3390/molecules25092009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
5 Hosseinabadi T, Lorigooini Z, Tabarzad M, Salehi B, Rodrigues CF, Martins N, Sharifi‐rad J. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer. Phytotherapy Research 2019;33:2849-61. [DOI: 10.1002/ptr.6470] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
6 Vue B, Zhang S, Vignau A, Chen G, Zhang X, Diaz W, Zhang Q, Zheng S, Wang G, Chen QH. O-Aminoalkyl-O-Trimethyl-2,3-Dehydrosilybins: Synthesis and In Vitro Effects Towards Prostate Cancer Cells. Molecules 2018;23:E3142. [PMID: 30501133 DOI: 10.3390/molecules23123142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Zhang X, Liu J, Zhang P, Dai L, Wu Z, Wang L, Cao M, Jiang J. Silibinin induces G1 arrest, apoptosis and JNK/SAPK upregulation in SW1990 human pancreatic cancer cells. Oncol Lett 2018;15:9868-76. [PMID: 29805688 DOI: 10.3892/ol.2018.8541] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 Vue B, Zhang X, Lee T, Nair N, Zhang S, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models. Bioorg Med Chem 2017;25:4845-54. [PMID: 28756013 DOI: 10.1016/j.bmc.2017.07.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
9 Rodriguez-Garcia A, Hevia D, Mayo JC, Gonzalez-Menendez P, Coppo L, Lu J, Holmgren A, Sainz RM. Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells. Redox Biol 2017;12:634-47. [PMID: 28391184 DOI: 10.1016/j.redox.2017.03.025] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
10 Huang S, Wang J, Cui Y. 2,2',4,4'-Tetrabromodiphenyl ether injures cell viability and mitochondrial function of mouse spermatocytes by decreasing mitochondrial proteins Atp5b and Uqcrc1. Environ Toxicol Pharmacol 2016;46:301-10. [PMID: 27525561 DOI: 10.1016/j.etap.2016.08.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
11 Deep G, Agarwal R. Chemopreventive Efficacy of Silymarin in Skin and Prostate Cancer. Integr Cancer Ther 2007;6:130-45. [DOI: 10.1177/1534735407301441] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 13.3] [Reference Citation Analysis]
12 Sagar SM. Future Directions for Research on Silybum marianum for Cancer Patients. Integr Cancer Ther 2007;6:166-73. [DOI: 10.1177/1534735407301566] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
13 Borek C. Dietary Antioxidants and Human Cancer. Integr Cancer Ther 2004;3:333-41. [DOI: 10.1177/1534735404270578] [Cited by in Crossref: 171] [Cited by in F6Publishing: 146] [Article Influence: 28.5] [Reference Citation Analysis]
14 Zhang S, Vue B, Huang M, Zhang X, Lee T, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells. Bioorg Med Chem Lett 2016;26:3226-31. [PMID: 27261177 DOI: 10.1016/j.bmcl.2016.05.069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Ting H, Deep G, Kumar S, Jain AK, Agarwal C, Agarwal R. Beneficial effects of the naturally occurring flavonoid silibinin on the prostate cancer microenvironment: role of monocyte chemotactic protein-1 and immune cell recruitment. Carcinogenesis 2016;37:589-99. [PMID: 27207648 DOI: 10.1093/carcin/bgw039] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
16 AbouZid SF, Chen SN, Pauli GF. Silymarin content in Silybum marianum populations growing in Egypt. Ind Crops Prod 2016;83:729-37. [PMID: 27182123 DOI: 10.1016/j.indcrop.2015.12.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
17 Vue B, Zhang S, Zhang X, Parisis K, Zhang Q, Zheng S, Wang G, Chen QH. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations. Eur J Med Chem 2016;109:36-46. [PMID: 26748997 DOI: 10.1016/j.ejmech.2015.12.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
18 Huang W, Zou K. Cytotoxicity of the saponin TTB2 on Ewing sarcoma cells. Exp Ther Med 2015;10:625-8. [PMID: 26622365 DOI: 10.3892/etm.2015.2544] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
19 Liou W, Chen L, Niu H, Yang T, Cheng J, Lin K. Herbal product silibinin-induced programmed cell death is enhanced by metformin in cervical cancer cells at the dose without influence on nonmalignant cells. J Appl Biomed 2015;13:113-21. [DOI: 10.1016/j.jab.2014.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
20 Jiang WG, Sanders AJ, Katoh M, Ungefroren H, Gieseler F, Prince M, Thompson SK, Zollo M, Spano D, Dhawan P, Sliva D, Subbarayan PR, Sarkar M, Honoki K, Fujii H, Georgakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Ye L, Helferich WG, Yang X, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Nowsheen S, Pantano F, Santini D. Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Semin Cancer Biol. 2015;35 Suppl:S244-S275. [PMID: 25865774 DOI: 10.1016/j.semcancer.2015.03.008] [Cited by in Crossref: 243] [Cited by in F6Publishing: 248] [Article Influence: 34.7] [Reference Citation Analysis]
21 Bitting RL, Schaeffer D, Somarelli JA, Garcia-Blanco MA, Armstrong AJ. The role of epithelial plasticity in prostate cancer dissemination and treatment resistance. Cancer Metastasis Rev 2014;33:441-68. [PMID: 24414193 DOI: 10.1007/s10555-013-9483-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
22 Ting HJ, Deep G, Jain AK, Cimic A, Sirintrapun J, Romero LM, Cramer SD, Agarwal C, Agarwal R. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2. Mol Carcinog 2015;54:730-41. [PMID: 24615813 DOI: 10.1002/mc.22135] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
23 Cheng KC, Asakawa A, Li YX, Chung HH, Amitani H, Ueki T, Cheng JT, Inui A. Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats. PLoS One 2014;9:e84550. [PMID: 24404172 DOI: 10.1371/journal.pone.0084550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
24 Ting H, Deep G, Agarwal C, Agarwal R. The strategies to control prostate cancer by chemoprevention approaches. Mutat Res 2014;760:1-15. [PMID: 24389535 DOI: 10.1016/j.mrfmmm.2013.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
25 Ting H, Deep G, Agarwal R. Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer. AAPS J 2013;15:707-16. [PMID: 23588585 DOI: 10.1208/s12248-013-9486-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
26 Anestopoulos I, Kavo A, Tentes I, Kortsaris A, Panayiotidis M, Lazou A, Pappa A. Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms. J Nutr Biochem 2013;24:586-94. [PMID: 22818713 DOI: 10.1016/j.jnutbio.2012.02.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
27 Zhang J, Luan Q, Liu Y, Lee DY, Wang Z. A Comparison of the Diastereoisomers, Silybin A and Silybin B, on the Induction of Apoptosis in K562 cells. Natural Product Communications 2011;6:1934578X1100601. [DOI: 10.1177/1934578x1100601122] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
28 Deep G, Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev 2010;29:447-63. [PMID: 20714788 DOI: 10.1007/s10555-010-9237-0] [Cited by in Crossref: 149] [Cited by in F6Publishing: 129] [Article Influence: 12.4] [Reference Citation Analysis]
29 Liu H, Du X, Yuan Q, Zhu L. Optimisation of enzyme assisted extraction of silybin from the seeds of Silybum marianum by Box-Behnken experimental design. Phytochem Anal 2009;20:475-83. [PMID: 19676047 DOI: 10.1002/pca.1149] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
30 Ye C, Liu Y, Wei D. Antioxidant and anticancer activity of 3‘-formyl-4’, 6‘-dihydroxy-2’-methoxy-5‘-methylchalcone and (2S)-8-formyl-5-hydroxy-7-methoxy-6-methylflavanone. Journal of Pharmacy and Pharmacology 2007;59:553-9. [DOI: 10.1211/jpp.59.4.0010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
31 Kang TJ, Lee SY, Singh RP, Agarwal R, Yim DS. Anti-tumor activity of oxypeucedanin from Ostericum koreanum against human prostate carcinoma DU145 cells. Acta Oncol 2009;48:895-900. [PMID: 19322700 DOI: 10.1080/02841860902824925] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
32 Thompson MD, Stushnoff C, Mcginley JN, Thompson HJ. In Vitro Measures Used to Predict Anticancer Activity of Apple Cultivars and Their Comparison to Outcomes From a Rat Model of Experimentally Induced Breast Cancer. Nutrition and Cancer 2009;61:510-7. [DOI: 10.1080/01635580902825563] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
33 Cui W, Gu F, Hu KQ. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009; 15(16): 1943-1950 [PMID: 19399925 DOI: 10.3748/wjg.15.1943] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
34 Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008;269:352-362. [PMID: 18472213 DOI: 10.1016/j.canlet.2008.03.053] [Cited by in Crossref: 229] [Cited by in F6Publishing: 193] [Article Influence: 16.4] [Reference Citation Analysis]
35 Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group. Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology 2008;47:605-12. [PMID: 18157835 DOI: 10.1002/hep.22044] [Cited by in Crossref: 95] [Cited by in F6Publishing: 87] [Article Influence: 6.8] [Reference Citation Analysis]
36 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
37 Stoiljkovic Z, Petrovic S, Ilic B. Examination of localization of silymarin and fatty oil in Silybum marianum (L.) Gaertn. fruit. CI&CEQ 2007;13:55-9. [DOI: 10.2298/ciceq0702055s] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
38 McCarty MF, Block KI. Multifocal angiostatic therapy: an update. Integr Cancer Ther 2005;4:301-14. [PMID: 16282507 DOI: 10.1177/1534735405282475] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
39 Hwang ES, Bowen PE. Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 2004;7:284-9. [PMID: 15383220 DOI: 10.1089/jmf.2004.7.284] [Cited by in Crossref: 76] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
40 Singh RP, Agarwal R. A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer. Mutat Res. 2004;555:21-32. [PMID: 15476849 DOI: 10.1016/j.mrfmmm.2004.05.017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
41 Thelen P, Wuttke W, Jarry H, Grzmil M, Ringert R. Inhibition of Telomerase Activity and Secretion of Prostate Specific Antigen by Silibinin in Prostate Cancer Cells. Journal of Urology 2004;171:1934-8. [DOI: 10.1097/01.ju.0000121329.37206.1b] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
42 Gallo D, Giacomelli S, Ferlini C, Raspaglio G, Apollonio P, Prislei S, Riva A, Morazzoni P, Bombardelli E, Scambia G. Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer. Eur J Cancer 2003;39:2403-10. [PMID: 14556934 DOI: 10.1016/s0959-8049(03)00624-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
43 Abascal K, Yarnell E. The Many Faces of Silybum marianum (Milk Thistle): Part 1 - Treating Cancer and Hyperlipidemia and Restoring Kidney Function. Alternative and Complementary Therapies 2003;9:170-5. [DOI: 10.1089/107628003322256878] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]